Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
July 18, 2017
DelMar Pharmaceuticals Announces Completion of First Site Initiation Visit for STAR-3 Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM
VANCOUVER, British Columbia and MENLO PARK, Calif., July 18, 2017 /PRNewswire/ -- DelMar Pharmaceuticals (DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on the ...
July 18, 2017
Kitov Announces Results of Study Demonstrating NT-219 Enhanced Efficacy of Keytruda® in Immune-Oncology Preclinical Model
TEL AVIV, Israel, July 18, 2017 /PRNewswire/ -- Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV) (KTOV), an innovative biopharmaceutical company, today announced  results of a pre-clinical study ...
July 18, 2017
Oramed Appoints Dr. Simon Bruce as Vice President of Medical Affairs
JERUSALEM, July 18, 2017 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (ORMP) (www.oramed.com), a developer of oral drug delivery systems, announced today the appointment of Dr. Simon ...
July 14, 2017
CTD Holdings to Present at 25th Annual Family Conference of the National Niemann-Pick Disease Foundation
ALACHUA, FL--(Marketwired - July 13, 2017) - CTD Holdings, Inc. (CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, ...
July 14, 2017
BioLife Solutions CryoStor® Cell Freeze Media Embedded in Invossa™: First Approved Cell and Gene Therapy for Osteoarthritis
BOTHELL, Wash., July 13, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading supplier of pre-formulated, clinical grade cell and tissue hypothermic storage and cryopreservation freeze ...
July 13, 2017
Aurinia Resolves Temporary Non-Compliance with Nasdaq’s Audit Committee Composition Rule
VICTORIA, British Columbia--(BUSINESS WIRE) -- Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”) today announced the receipt of a letter from The NASDAQ Stock ...
July 13, 2017
BioTime Subsidiary AgeX Therapeutics Appoints Aubrey de Grey, Ph.D. as VP of New Technology Discovery
ALAMEDA, Calif. & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE) -- AgeX Therapeutics (“AgeX”), a subsidiary of BioTime, Inc. (NYSE MKT:BTX) with a focus on developing new therapies in the ...
July 13, 2017
CytoSorbents Awarded $1 Million STTR Phase II Contract To Advance Development of Life-Saving Universal Plasma
MONMOUTH JUNCTION, N.J., July 13, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a leader in critical care immunotherapy specializing in blood purification, today announced that it ...
July 13, 2017
IMMUNE Pharmaceuticals’ Oncology Subsidiary, CYTOVIA, Announces the Filing of a World-Wide Patent Protecting the Use of Ceplene® in Acute Myeloid Leukemia (AML) and Other Hematological Cancers with Mutated NPM1
NEW YORK--(BUSINESS WIRE) -- Cytovia, Inc. (“Cytovia”) the oncology subsidiary of Immune Pharmaceuticals Inc. (IMNP) ("Immune" or the “Company”), a clinical stage biopharmaceutical company, announced the ...
July 13, 2017
Achaogen Appoints Dr. Karen Bernstein to its Board of Directors
SOUTH SAN FRANCISCO, Calif., July 13, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
July 13, 2017
Advaxis Lead Immunotherapy Candidate Continues to Build Recognition Among Industry Leaders
PRINCETON, N.J.--(BUSINESS WIRE) -- Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products based on its proprietary Lm-based ...
July 12, 2017
BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada) For The Licensing And Distribution Rights Of BELBUCA® In Canada
RALEIGH, N.C. and PICKERING, Ontario, July 12, 2017 /PRNewswire/ -- Today, BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company with a focus in pain management ...
July 12, 2017
Oramed to Present at BIT'S 5th World Congress of Diabetes on July 13, 2017
JERUSALEM, July 12, 2017 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced ...
July 11, 2017
VBI Vaccines Announces Phase 3 Clinical Program for Sci-B-Vac(TM) Hepatitis B Vaccine
CAMBRIDGE, MASSACHUSETTS--(Marketwired - Jul 11, 2017) - VBI Vaccines Inc. (VBIV)(VBV.TO) ("VBI") announced today its plans for a global Phase 3 clinical program for Sci-B-Vac™, ...
July 11, 2017
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
SAN DIEGO, July 11, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that it intends to offer and sell, subject to market and other ...
July 11, 2017
Cytovia Inc, Immune Pharmaceuticals’ Oncology Subsidiary, Enters into a Definitive Agreement with Pint Pharma for the Licensing and Commercialization of Ceplene® in Latin America
NEW YORK--(BUSINESS WIRE) -- Cytovia Inc. (“Cytovia”) the oncology subsidiary of Immune Pharmaceuticals Inc. (NASDAQ: IMNP) ("Immune") announced today that it has entered into a licensing agreement ...
July 11, 2017
Arena Pharmaceuticals Reports Positive Topline Phase 2 Results for Ralinepag in Patients with Pulmonary Arterial Hypertension
SAN DIEGO, July 10, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), today announced positive Phase 2 results for ralinepag, an investigational, long-acting, orally administered prostacyclin receptor ...
July 11, 2017
Aeglea BioTherapeutics Appoints James Wooldridge, M.D. as Chief Medical Officer
AUSTIN, Texas, July 10, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino ...
July 11, 2017
Prometic Announces Positive Long Term Clinical Data on Ryplazym™ in Plasminogen Congenital Deficiency and Provides Regulatory Update
LAVAL, QC, July 11, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) ("Prometic" or the "Corporation") today announced new long-term clinical data from its ...
July 11, 2017
DelMar Pharmaceuticals Appoints Saiid Zarrabian to the Board of Directors and Names Dr. Erich Mohr as Chairman
VANCOUVER, British Columbia and MENLO PARK, Calif., July 11, 2017 /PRNewswire/ -- DelMar Pharmaceuticals (DMPI) ("DelMar" and the "Company"), a biopharmaceutical company developing new cancer therapies, ...
Page 151 of 162